Why is Kestra Medical Technologies Ltd. ?
1
With a growth in Net Sales of 16.64%, the company declared Very Positive results in Apr 26
- NET PROFIT(HY) Higher at USD -72.86 MM
- NET SALES(Q) Highest at USD 28.64 MM
- RAW MATERIAL COST(Y) Fallen by -24.19% (YoY)
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 95.25%, its profits have fallen by -24%
3
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating Performance
- The stock has generated a return of 95.25% in the last 1 year, much higher than market (S&P 500) returns of 21.34%
How much should you hold?
- Overall Portfolio exposure to Kestra Medical Technologies Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
180.00%
EBIT Growth (5y)
-17.71%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.94
EV to EBIT
-6.18
EV to EBITDA
-6.55
EV to Capital Employed
22.78
EV to Sales
10.59
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-368.81%
ROE (Latest)
-50.76%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
Bollinger Bands
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Movement
17What is working for the Company
NET PROFIT(HY)
Higher at USD -72.86 MM
NET SALES(Q)
Highest at USD 28.64 MM
RAW MATERIAL COST(Y)
Fallen by -24.19% (YoY
OPERATING PROFIT MARGIN(Q)
Highest at -129.27 %
-5What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -81.7 MM
DEBT-EQUITY RATIO
(HY)
Highest at -57.63 %
Here's what is working for Kestra Medical Technologies Ltd.
Net Sales
Highest at USD 28.64 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Net Sales
At USD 28.64 MM has Grown at 36.83%
over average net sales of the previous four periods of USD 20.93 MMMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Net Profit
Higher at USD -72.86 MM
than preceding 12 month period ended Apr 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Operating Profit Margin
Highest at -129.27 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Raw Material Cost
Fallen by -24.19% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Kestra Medical Technologies Ltd.
Operating Cash Flow
Lowest at USD -81.7 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Debt-Equity Ratio
Highest at -57.63 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






